Response Genetics Inc (RGDXQ) Financial Statements (2024 and earlier)

Company Profile

Business Address 1640 MARENGO ST.,
LOS ANGELES,, CA 90033
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,2225,9592,1374,9578,1494,590
Cash and cash equivalents2,2225,9592,1374,9578,1494,590
Receivables7,8106,8896,5305,5296,2267,176
Other undisclosed current assets1,1839971,1471,334982575
Total current assets:11,21613,8459,81311,81915,35612,341
Noncurrent Assets
Property, plant and equipment1,4061,5371,6921,7671,9351,892
Intangible assets, net (including goodwill)631680718773767765
Intangible assets, net (excluding goodwill)631680718773767765
Deferred costs  202    
Other noncurrent assets192     
Total noncurrent assets:2,2292,4192,4102,5392,7022,657
TOTAL ASSETS:13,44516,26512,22314,35818,05814,998
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,9793,4284,0713,8294,2123,087
Interest and dividends payable150201    
Employee-related liabilities1,5481,4181,9071,9281,8511,484
Accounts payable1,6101,3991,6581,3841,6941,083
Accrued liabilities672410506517667519
Debt101931011,129157192
Other undisclosed current liabilities9681,1701,4421,3491,2941,170
Total current liabilities:5,0484,6905,6146,3075,6634,449
Noncurrent Liabilities
Long-term debt and lease obligation9,5679,5651,5951161,1361,156
Long-term debt, excluding current maturities9,4649,4401,500 1,0001,000
Capital lease obligations10312595116136156
Total noncurrent liabilities:9,5679,5651,5951161,1361,156
Total liabilities:14,61514,2557,2096,4236,7995,605
Temporary equity, carrying amount    5,5005,5005,500
Equity
Equity, attributable to parent, including:(1,170)2,0105,0142,4355,7593,893
Common stock388387387337337293
Additional paid in capital77,69877,49676,85771,18970,98665,983
Accumulated other comprehensive loss(260)(289)(290)(290)(267)(267)
Accumulated deficit(78,997)(75,584)(71,941)(68,802)(65,297)(62,116)
Warrants and rights outstanding681681    
Other undisclosed equity, attributable to parent(681)(681)    
Total equity:(1,170)2,0105,0142,4355,7593,893
TOTAL LIABILITIES AND EQUITY:13,44516,26512,22314,35818,05814,998

Income Statement (P&L) ($ in thousands)

3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
Revenues
(Revenue, Net)
4,0794,4654,2813,8954,7714,092
Cost of revenue7,129(2,543)(2,586)(2,438)(2,474)(2,740)
Cost of goods and services sold (2,543)(2,586)(2,438)(2,474)(2,740)
Other undisclosed gross profit (9,574)     
Gross profit:1,6351,9221,6951,4572,2971,352
Operating expenses(4,702)(5,277)(4,803)(4,934)(5,448)(4,089)
Operating loss:(3,068)(3,354)(3,108)(3,478)(3,152)(2,737)
Nonoperating income (expense)14(30)(8)(2)(3)45
Interest and debt expense(358)(259)(23)(24)(26)(26)
Loss from continuing operations before equity method investments, income taxes:(3,412)(3,644)(3,139)(3,504)(3,181)(2,718)
Other undisclosed income from continuing operations before income taxes     0 
Loss from continuing operations:(3,412)(3,644)(3,139)(3,504)(3,181)(2,718)
Loss before gain (loss) on sale of properties:(3,412)(3,644)(3,139)(3,504)(3,181)(2,718)
Net loss:(3,412)(3,644)(3,139)(3,504)(3,181)(2,718)
Other undisclosed net income (loss) attributable to parent (0)000(0)0
Net loss available to common stockholders, diluted:(3,412)(3,644)(3,139)(3,504)(3,181)(2,718)

Comprehensive Income ($ in thousands)

3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
Net loss:(3,412)(3,644)(3,139)(3,504)(3,181)(2,718)
Comprehensive loss:(3,412)(3,644)(3,139)(3,504)(3,181)(2,718)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent291(1)(22)(1)(1)
Comprehensive loss, net of tax, attributable to parent:(3,383)(3,643)(3,140)(3,527)(3,182)(2,719)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: